Plain-English translation of NCT04165070 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Carcinoma, Non-Small-Cell Lung research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing whether , combined with other new experimental medications and chemotherapy drugs, can help treat advanced lung cancer better than current standard treatments. You would receive these medications through IV infusions, with an initial intensive treatment phase followed by a longer maintenance phase. The study is designed for people with advanced lung cancer who have not yet received any systemic treatment.
Advanced lung cancer is very difficult to treat, and doctors are looking for better ways to combine different types of cancer-fighting drugs to improve survival and quality of life for patients.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic regularly to receive IV infusions of the study medications on a set schedule. The first 4 treatment cycles (each lasting 3 weeks) would include chemotherapy drugs along with the new medications, followed by a maintenance phase where you would continue the new medications alone for up to 2 years total. You would have blood tests, imaging scans, and check-ins to monitor how well the treatment is working and watch for any side effects.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
United States